Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: J Neurochem. 2010 Dec 13;116(3):406–414. doi: 10.1111/j.1471-4159.2010.07121.x

Figure 4.

Figure 4

An example showing CCL2 enhancement of EPSCs was blocked by co-application of NMDA and AMPA receptor antagonists. All current traces were recorded from the same cell with a hold potential of −70mV. Bath co-application of APV (50 μM) and CNQX 10 μM completely blocked the effects of CCL2 enhancement of EPSCs.